In 2023, the hospital discharges for malignant neoplasm of the prostate in Belgium stood at 116.7 units per hundred thousand persons. The forecasted data from 2024 to 2028 shows a gradual decline in hospital discharges, with values decreasing from 115.8 to 112.3 units per hundred thousand persons. The year-on-year percentage variations show slight declines: 2024 to 2025 (-0.78%), 2025 to 2026 (-0.78%), 2026 to 2027 (-0.79%), and 2027 to 2028 (-0.71%). Over the last two years, this trend suggests a steady reduction in prostate cancer-related hospitalizations.
The compound annual growth rate (CAGR) over the five-year forecast period from 2024 to 2028 indicates an average annual decline of approximately -0.95%.
Future trends to watch for include advancements in early detection and treatment methods, which may further reduce hospital discharges, and potential demographic changes such as an aging population that could impact the incidence rate of malignant neoplasm of the prostate.
